Media

All news HealthCap news Interviews

December 05, 2014

Oncopeptides Presents Encouraging Preliminary Phase I/ II Clinical Data with Melflufen and Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma at the 56th ASH Annual Meeting and Exposition.

December 04, 2014

Oncos Therapeutics recruits Dr Magnus Jaderberg as CMO

December 02, 2014

Nordic Nanovector To Present Clinical Data from Phase I/II Trial on Betalutin™ at Upcoming American Society of Hematology (ASH) Meeting

December 02, 2014

Cerenis Therapeutics reports two postivie phase II studies

December 02, 2014

Oncos Therapeutics granted US and EU Orphan Drug Designation

December 02, 2014

Aerocrine announce that NICE guidelines support the FeNO measurement in diagnosis and management of asthma

December 02, 2014

Cerenis Reports Top-Line Phase II Results for its HDL Mimetic CER-001

November 28, 2014

AEROCRINE AB strengthens its financial position by a rights issue of approximately SEK 445 million

November 27, 2014

Aerocrine Interim report January – September 2014

November 27, 2014

Nordic Nanovector and Affibody collaborate on advanced radio-immunotherapies program for Multiple Myeloma